Stock News
Teva: Don’t Be Too Worried About The Debt – Teva Pharmaceutical Industries Limited (NYSE:TEVA)
In my previous article Teva Pharmaceutical: Generidiculous!, I highlighted the generic giant’s growth avenues and valuation metrics, which I concluded to be undervalued. Since the release of the article, even though it wasn’t all that […]